A study for a 20 year old woman who takes Onfi - from FDA reports


Summary

246 females aged 20 (±5) who take the same drug are studied. This is a personalized study for a 20 year old female patient who has Epilepsy. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Apr, 25, 2017

246 females aged 20 (±5) who take Onfi are studied.


Number of reports submitted per year:

Onfi for a 20-year old woman.

Information of the patient in this study:

  • Age: 20
  • Gender: female
  • Conditions: Epilepsy
  • Drugs taken:
    • Onfi (clobazam)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • hallucination, visual
  • depersonalisation
  • memory loss
  • sensory disturbance
  • epilepsy
  • status epilepticus
  • drowsiness
  • rash morbilliform
  • nausea and vomiting
  • headache
1 - 6 months:
  • hepatic failure
  • irritability
  • hepatic steatosis
  • hepatitis toxic
  • diarrhea
  • drug ineffective
  • headache
  • the flu
  • liver transplant
  • aggression
6 - 12 months:
n/a
1 - 2 years:
  • anger
  • head banging
  • rashes
  • urticaria
  • aggression
2 - 5 years:
n/a
5 - 10 years:
  • chronic hepatitis
  • calculus bladder
  • aggression
  • agitation
10+ years:
n/a
not specified:
  • convulsion
  • seizures
  • drowsiness
  • drug ineffective
  • memory loss
  • fatigue
  • fever
  • rashes
  • status epilepticus
  • birth control

Top conditions involved for these people *:

  • Epilepsy (101 people, 41.06%)
  • Seizures (24 people, 9.76%)
  • Convulsion (16 people, 6.50%)
  • Complex Partial Seizures (13 people, 5.28%)
  • Depression (10 people, 4.07%)

Top co-used drugs for these people *:

  • Keppra (54 people, 21.95%)
  • Lamictal (39 people, 15.85%)
  • Lamotrigine (37 people, 15.04%)
  • Topiramate (36 people, 14.63%)
  • Vimpat (30 people, 12.20%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Onfi, Epilepsy

You may be interested in these reviews

More reviews for: Onfi, Epilepsy